Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 01:56
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Rhetan Sees a Shift in Fortunes as Gross Margin Accelerates to 39.24%, up from -20%.
The company's revenue growth, however, decelerates to , down from 300%. Meanwhile, its marginal operating leverage declines to , a decrease from . Despite this, the stock price surges, with a daily price change of , and a close price of , up from 22.03 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 39.24 % | -20 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -20 % | 54.11 | ▼ |
| REVENUE_GROWTH_YOY | -19.3 % | 300 | ▼ |
| PRICE_CHANGE_PERCENT | 9.941 % | — | - |
| DAILY_VOLUME | 3,86,09,598 shares | 1,00,24,718 | ▲ |
| CLOSE_PRICE | 24.22 INR | 22.03 | ▲ |